Linkedin
Facebook
Twitter
Youtube

23 Feb Caribou Biosciences

Posted at 18:55h in by

Rachel Haurwitz, Ph.D., President and CEO

Berkeley, CA
(NASDAQ: CRBU)

Virtual Presentation

Caribou Biosciences is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging a proprietary technology to develop genome-edited, off-the-shelf CAR T and CAR-NK cell therapies for a range of tumor types. The company’s chRDNA technology has demonstrated superior specificity and high efficiency in preclinical studies, which enables the performance of multiple, precise genomic edits while maintaining genomic integrity. The company uses its chRDNA technology to enhance its cell therapies by creating genomic edits to improve persistence of antitumor activity, including removing the PD-1 checkpoint in order to reduce premature CAR T cell exhaustion and immune cloaking the cell therapy to prevent rapid rejection by the patient’s immune system.
www.cariboubio.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 11-13, 2022
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions